I Sverige kan lkemedel mot fetma bli aktuella om: Du har ett BMI p 30 eller hgre (fetma) Du har ett BMI p 27 eller hgre och samtidigt lider av viktrelaterade sjukdomar, till exempel typ 2-diabetes eller hgt blodtryck Innan behandling stts in gr lkaren alltid en individuell bedmning
This division underscores the complex considerations behind coverage decisions, as stakeholders weigh the clinical realities of obesity against beliefs about personal responsibility and concerns about long-term benefit
Patience combined with consistent daily dosing produces the best outcomes
Patients discontinuing GLP-1 medications should monitor for signs of gallbladder problems (severe abdominal pain, especially after meals), pancreatitis (persistent severe abdominal pain, sometimes with vomiting), or significant hyperglycemia
The appropriate angle may also depend on needle length and device design
With Medicare currently prohibited by law from covering prescription drugs used for weight loss, six in ten adults say they think Medicare should cover the cost of these drugs when prescribed for weight loss for people who are overweight, including more than half of Democrats, independents and Republicans
